We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network.
- Authors
Dias-Santagata, Dora; Heist, Rebecca S; Bard, Adam Z; Silva, Annacarolina F L da; Dagogo-Jack, Ibiayi; Nardi, Valentina; Ritterhouse, Lauren L; Spring, Laura M; Jessop, Nicholas; Farahani, Alexander A; Mino-Kenudson, Mari; Allen, Jill; Goyal, Lipika; Parikh, Aparna; Misdraji, Joseph; Shankar, Ganesh; Jordan, Justin T; Martinez-Lage, Maria; Frosch, Matthew; Graubert, Timothy
- Abstract
Background Precision oncology relies on molecular diagnostics, and the value-proposition of modern healthcare networks promises a higher standard of care across partner sites. We present the results of a clinical pilot to standardize precision oncology workflows. Methods Workflows are defined as the development, roll-out, and updating of disease-specific molecular order sets. We tracked the timeline, composition, and effort of consensus meetings to define the combination of molecular tests. To assess clinical impact, we examined order set adoption over a two-year period (before and after roll-out) across all gastrointestinal and hepatopancreatobiliary (GI) malignancies, and by provider location within the network. Results Development of 12 disease center-specific order sets took ~9 months, and the average number of tests per indication changed from 2.9 to 2.8 (P =.74). After roll-out, we identified significant increases in requests for GI patients (17%; P <.001), compliance with testing recommendations (9%; P <.001), and the fraction of "abnormal" results (6%; P <.001). Of 1088 GI patients, only 3 received targeted agents based on findings derived from non-recommended orders (1 before and 2 after roll-out); indicating that our practice did not negatively affect patient treatments. Preliminary analysis showed 99% compliance by providers in network sites, confirming the adoption of the order sets across the network. Conclusion Our study details the effort of establishing precision oncology workflows, the adoption pattern, and the absence of harm from the reduction of non-recommended orders. Establishing a modifiable communication tool for molecular testing is an essential component to optimize patient care via precision oncology.
- Subjects
ACCURACY; WORKFLOW; HUMAN services programs; ONCOLOGY
- Publication
Oncologist, 2022, Vol 27, Issue 11, p930
- ISSN
1083-7159
- Publication type
Article
- DOI
10.1093/oncolo/oyac134